Cover Image
市場調查報告書

PIQUR Therapeutics AG:產品平台分析

PIQUR Therapeutics AG - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 257884
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
PIQUR Therapeutics AG:產品平台分析 PIQUR Therapeutics AG - Product Pipeline Review - 2015
出版日期: 2015年02月24日 內容資訊: 英文 28 Pages
簡介

PIQUR Therapeutics AG (PIQUR)是致力於基於脂質激酶 (PI3k) 及mTOR抑制劑,開發腫瘤及發炎性疾病治療用創新小分子藥的製藥公司。提供胰臟癌,神經膠質瘤,甲狀腺癌,乳癌,非小細胞肺癌,胃癌,腸胃間質腫瘤,膽管癌等腫瘤治療藥,努力配合患者和醫學界的需求。

本報告提供PIQUR Therapeutics AG 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

PIQUR Therapeutics AG的基本資料

  • PIQUR Therapeutics AG概要
  • 主要資訊
  • 企業資料

PIQUR Therapeutics AG :R&D概要

  • 主要的治療範圍

PIQUR Therapeutics AG :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

PIQUR Therapeutics AG :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

PIQUR Therapeutics AG :藥物簡介

  • PQR-309
  • PQR-401
  • PQR-5XX
  • PQR-6XX
  • PQR-311
  • PQR-316
  • Small Molecules for Undisclosed Indication

PIQUR Therapeutics AG :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

PIQUR Therapeutics AG :最近的開發平台趨勢

PIQUR Therapeutics AG :暫停中的計劃

PIQUR Therapeutics AG :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06795CDB

Summary

Global Markets Direct's, 'PIQUR Therapeutics AG - Product Pipeline Review - 2015', provides an overview of the PIQUR Therapeutics AG's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of PIQUR Therapeutics AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of PIQUR Therapeutics AG including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of PIQUR Therapeutics AG's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the PIQUR Therapeutics AG's pipeline products

Reasons to buy

  • Evaluate PIQUR Therapeutics AG's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of PIQUR Therapeutics AG in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the PIQUR Therapeutics AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of PIQUR Therapeutics AG and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of PIQUR Therapeutics AG
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of PIQUR Therapeutics AG and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • PIQUR Therapeutics AG Snapshot
    • PIQUR Therapeutics AG Overview
    • Key Information
    • Key Facts
  • PIQUR Therapeutics AG - Research and Development Overview
    • Key Therapeutic Areas
  • PIQUR Therapeutics AG - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • PIQUR Therapeutics AG - Pipeline Products Glance
    • PIQUR Therapeutics AG - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • PIQUR Therapeutics AG - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • PIQUR Therapeutics AG - Drug Profiles
    • PQR-309
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PQR-401
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PQR-5XX
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PQR-6XX
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PQR-311
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PQR-316
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • PIQUR Therapeutics AG - Pipeline Analysis
    • PIQUR Therapeutics AG - Pipeline Products by Target
    • PIQUR Therapeutics AG - Pipeline Products by Route of Administration
    • PIQUR Therapeutics AG - Pipeline Products by Molecule Type
    • PIQUR Therapeutics AG - Pipeline Products by Mechanism of Action
  • PIQUR Therapeutics AG - Recent Pipeline Updates
  • PIQUR Therapeutics AG - Dormant Projects
  • PIQUR Therapeutics AG - Locations And Subsidiaries
  • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • PIQUR Therapeutics AG, Key Information
  • PIQUR Therapeutics AG, Key Facts
  • PIQUR Therapeutics AG - Pipeline by Indication, 2015
  • PIQUR Therapeutics AG - Pipeline by Stage of Development, 2015
  • PIQUR Therapeutics AG - Monotherapy Products in Pipeline, 2015
  • PIQUR Therapeutics AG - Phase I, 2015
  • PIQUR Therapeutics AG - Preclinical, 2015
  • PIQUR Therapeutics AG - Discovery, 2015
  • PIQUR Therapeutics AG - Pipeline by Target, 2015
  • PIQUR Therapeutics AG - Pipeline by Route of Administration, 2015
  • PIQUR Therapeutics AG - Pipeline by Molecule Type, 2015
  • PIQUR Therapeutics AG - Pipeline Products by Mechanism of Action, 2015
  • PIQUR Therapeutics AG - Recent Pipeline Updates, 2015
  • PIQUR Therapeutics AG - Dormant Developmental Projects,2015

List of Figures

  • PIQUR Therapeutics AG - Pipeline by Top 10 Indication, 2015
  • PIQUR Therapeutics AG - Pipeline by Stage of Development, 2015
  • PIQUR Therapeutics AG - Monotherapy Products in Pipeline, 2015
  • PIQUR Therapeutics AG - Pipeline by Top 10 Target, 2015
  • PIQUR Therapeutics AG - Pipeline by Top 10 Molecule Type, 2015
  • PIQUR Therapeutics AG - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top